Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Imaflex Inc
V.IFX
Alternate Symbol(s):
IFLXF
Consumer Cyclical
Packaging & Containers
Imaflex Inc. is focused on the development and manufacturing of solutions for the flexible packaging and agriculture industries. The Company’s products consist primarily of polyethylene (plastic) film and bags, including metalized plastic film, for the industrial, agricultural and consumer markets. Its polyethylene films are mainly sold to printers known as converters, who process the film into...
a finished product to meet their end-customer needs. Additionally, its films are sold directly to customers to protect and market their own products or bought by distributors for re-sale. Its agricultural films are finished products, predominantly sold directly by the Company to growers. Its portfolio includes common mulch, compostable and fumigant barrier films, as well as metalized crop protection films that add pest/weed control and/or accelerated growth benefits beyond those provided by its common mulch films. It has manufacturing facilities in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:IFX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
(12)
•••
Paddy902
X
Comment by
Paddy902
on Apr 14, 2022 10:15am
RE:Year end results
I thought it all looked pretty good, markets not impressed but I am fine with that in the short term....thats typically the best way to make some money, take advantage of the inefficiencies of the
...more
(1653)
•••
Ciao
X
Post by
Ciao
on Apr 14, 2022 6:54am
Year end results
Q4 was impacted by increasing resin prices which they can pass to customers but with a 30 day lag. Q1 rev will exceed q4 rev. They believe they are at the start of a multi-year growth cycle. No
...more
(1653)
•••
Ciao
X
Post by
Ciao
on Apr 12, 2022 9:37pm
new board member
MONTRAL, April 12, 2022 /CNW Telbec/ - Imaflex Inc. ("Imaflex" or the "Corporation") (TSXV: IFX), announces the appointment of Roberto Longo to the Corporation&
...more
(12)
•••
Paddy902
X
Comment by
Paddy902
on Apr 12, 2022 9:20pm
RE:RE:RE:RE:RE:RE:nice uptick as we get closer to yr end numbers April 14th
Certainly been a few good days, the shares at from last month looking like a smart move. Would love to see $1.80.
(156)
•••
Daudau11
X
Comment by
Daudau11
on Apr 12, 2022 9:36am
RE:RE:RE:RE:RE:nice uptick as we get closer to yr end numbers April 14th
Don't believe they ever had a conference call before.
(1653)
•••
Ciao
X
Comment by
Ciao
on Apr 11, 2022 10:58am
RE:RE:RE:RE:nice uptick as we get closer to yr end numbers April 14th
The 14th, that's this Thursday. I haven't seen the invite for the conference call, do they have one?
(460)
•••
microcaphobby
X
Comment by
microcaphobby
on Apr 11, 2022 10:14am
RE:RE:RE:nice uptick as we get closer to yr end numbers April 14th
They did not pre-announce last year. I understand the numbers will be out before the market opens on the 14th.
(1653)
•••
Ciao
X
Comment by
Ciao
on Apr 11, 2022 9:53am
RE:RE:nice uptick as we get closer to yr end numbers April 14th
Now we have a similar sized wall at $1.40 to be taken down. Do they pre-anounce the release for year end results?
(1653)
•••
Ciao
X
Comment by
Ciao
on Apr 09, 2022 4:34pm
RE:RE:Board member resignation
He wasn't the CFO.
(2)
•••
Newport25
X
Comment by
Newport25
on Apr 09, 2022 2:24pm
RE:Board member resignation
pretty sure he just got a better offer somewhere else when the results are good, CFO's get lot of credits
(2)
•••
Newport25
X
Post by
Newport25
on Apr 09, 2022 2:22pm
net earnings FY 2022
Expect at least 11M$ net earnings FY 2022. Do the maths, trading at 65 ish millions. easily a 100M market cap by this summer, at least 50% gain from right now.
(1653)
•••
Ciao
X
Comment by
Ciao
on Apr 08, 2022 11:08am
RE:nice uptick as we get closer to yr end numbers April 14th
Those few shares at $1.30 have been there forever, but yeah, based on liquidity, those look like "blocks". Nonetheless very positive to see them being taken out.
(460)
•••
microcaphobby
X
Post by
microcaphobby
on Apr 08, 2022 10:55am
nice uptick as we get closer to yr end numbers April 14th
Fertilizer products are in high demand and agriculture stocks are performing much better as food shortages gontinue and high fertilizer prices take hold. These products are the
...more
(1653)
•••
Ciao
X
Comment by
Ciao
on Mar 28, 2022 11:22am
RE:RE:advaseal
The lab is still working on this, some impurities found in the ingredients need to be taken into account. Year end results will be out on April 14, we should here more on the timeline.
(460)
•••
microcaphobby
X
Comment by
microcaphobby
on Mar 26, 2022 11:58pm
RE:advaseal
We might get a better indication of the timeline when they issue their year end results in mid April.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Tribe Announces Preliminary Q4-2024 Results, Achieving Positive Adjusted EBITDA and Increased Revenue Run-Rate
Creating a Non-Opioid Solution for Chronic Pain Management